In immunology, Novartis develops medicines for diseases in which the immune system does not function properly, such as chronic inflammatory and autoimmune diseases. The focus is on treating the underlying causes of disease, not just the symptoms. The goal is to help patients manage their condition better, with fewer flare-ups and improved quality of daily life.